Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

NCT05834426 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sociedad de Lucha Contra el Cáncer del Ecuador